These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2547134)

  • 21. Re: Trends in the treatment of ductal carcinoma in situ of the breast.
    Intra M; Rotmensz N; Viale G; Veronesi U
    J Natl Cancer Inst; 2004 Jul; 96(14):1110-1. PubMed ID: 15265976
    [No Abstract]   [Full Text] [Related]  

  • 22. Challenge in the treatment of estrogen-receptor-negative ductal carcinoma in situ.
    Altundag K
    J Clin Oncol; 2005 Jul; 23(19):4469-70. PubMed ID: 15994163
    [No Abstract]   [Full Text] [Related]  

  • 23. Insulin-like growth factor-I inhibition with pasireotide decreases cell proliferation and increases apoptosis in pre-malignant lesions of the breast: a phase 1 proof of principle trial.
    Singh B; Smith JA; Axelrod DM; Ameri P; Levitt H; Danoff A; Lesser M; de Angelis C; Illa-Bochaca I; Lubitz S; Huberman D; Darvishian F; Kleinberg DL
    Breast Cancer Res; 2014 Nov; 16(6):463. PubMed ID: 25385439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast tumors: evaluation with P-31 MR spectroscopy.
    Degani H; Horowitz A; Itzchak Y
    Radiology; 1986 Oct; 161(1):53-5. PubMed ID: 3020609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is radiotherapy as curative as mastectomy for patients with ductal carcinoma in situ?
    Harris JR; Schnitt SJ
    Int J Radiat Oncol Biol Phys; 1990 Oct; 19(4):1091-2; discussion 1103. PubMed ID: 2170303
    [No Abstract]   [Full Text] [Related]  

  • 26. HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells.
    Krop IE; Sgroi D; Porter DA; Lunetta KL; LeVangie R; Seth P; Kaelin CM; Rhei E; Bosenberg M; Schnitt S; Marks JR; Pagon Z; Belina D; Razumovic J; Polyak K
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9796-801. PubMed ID: 11481438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pathological findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Intraductal carcinoma (ductal carcinoma in situ)].
    Haase W
    Strahlenther Onkol; 1996 Feb; 172(2):109-10. PubMed ID: 8669043
    [No Abstract]   [Full Text] [Related]  

  • 28. Breast conservation therapy for ductal carcinoma in situ.
    Fowble BL
    Int J Radiat Oncol Biol Phys; 1993 Jun; 26(3):547-8; discussion 549. PubMed ID: 8390423
    [No Abstract]   [Full Text] [Related]  

  • 29. The role of aromatase inhibitors in the management of ductal carcinoma in situ with an estrogen receptor-positive/progesterone receptor-negative/Her-2/neu receptor-positive pattern.
    Altundag K; Bulut N; Sari E; Harputluoglu H
    Am J Surg; 2007 Aug; 194(2):272-3. PubMed ID: 17618822
    [No Abstract]   [Full Text] [Related]  

  • 30. Radiotherapy for ductal carcinoma in situ detected by screening.
    Hamilton CR; Buchanan RB
    BMJ; 1990 Jul; 301(6745):224-5. PubMed ID: 2168228
    [No Abstract]   [Full Text] [Related]  

  • 31. Should all patients undergoing breast conserving therapy for DCIS receive radiation therapy? No. One size does not fit all: an argument against the routine use of radiation therapy for all patients with ductal carcinoma in situ of the breast who elect breast conservation.
    Silverstein MJ; Lagios MD
    J Surg Oncol; 2007 Jun; 95(8):605-9. PubMed ID: 17192948
    [No Abstract]   [Full Text] [Related]  

  • 32. Should all patients undergoing breast conserving therapy for DCIS receive radiation therapy? Yes. Radiation therapy, an important component of breast conserving treatment for patients with ductal carcinoma in situ of the breast.
    Buchholz TA; Haffty BG; Harris JR
    J Surg Oncol; 2007 Jun; 95(8):610-3. PubMed ID: 17221862
    [No Abstract]   [Full Text] [Related]  

  • 33. Proceedings: Correlations between certain biochemical properties of breast cancer and response to therapy: a preliminary report.
    Savlov ED; Wittliff JL; Hilf R; Hall TC
    Cancer; 1974 Feb; 33(2):303-9. PubMed ID: 4360053
    [No Abstract]   [Full Text] [Related]  

  • 34. Letter: Hormone assays on breast-tumour.
    Hoge A; Hartsuck JM; Nordquist RE
    Lancet; 1974 Apr; 1(7859):678-9. PubMed ID: 4132342
    [No Abstract]   [Full Text] [Related]  

  • 35. Ten-year results of breast-conserving surgery and definitive irradiation for intraductal carcinoma (ductal carcinoma in situ) of the breast.
    Solin LJ; Recht A; Fourquet A; Kurtz J; Kuske R; McNeese M; McCormick B; Cross MA; Schultz DJ; Bornstein BA
    Cancer; 1991 Dec; 68(11):2337-44. PubMed ID: 1657351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differentiation between cancerous and normal hyperplastic lobules in breast lesions.
    Slater M; Danieletto S; Pooley M; Cheng Teh L; Gidley-Baird A; Barden JA
    Breast Cancer Res Treat; 2004 Jan; 83(1):1-10. PubMed ID: 14997049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiation beats tamoxifen after DCIS treatment.
    Health News; 2003 Sep; 9(9):8. PubMed ID: 14584475
    [No Abstract]   [Full Text] [Related]  

  • 38. Basal cell-specific and hyperproliferation-related keratins in human breast cancer.
    Wetzels RH; Kuijpers HJ; Lane EB; Leigh IM; Troyanovsky SM; Holland R; van Haelst UJ; Ramaekers FC
    Am J Pathol; 1991 Mar; 138(3):751-63. PubMed ID: 1705754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Minimal carcinoma of the breast].
    Leggeri A; Roseano M; Bortul M; Calligaris L
    Ann Ital Chir; 1991; 62(5):427-31. PubMed ID: 1666274
    [No Abstract]   [Full Text] [Related]  

  • 40. Phenotypic alterations in myoepithelial cells of the breast in normal and pathologic conditions.
    Pusztaszeri M
    Am J Surg Pathol; 2010 Dec; 34(12):1886; author reply 1886-7. PubMed ID: 21107098
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.